Global Egg Protein in Pharmaceuticals Market, By Type (Egg White Powder, Egg Yolk Powder, Whole Egg Protein), Flavour (Flavoured, Regular), Form (Liquid, Powder, Solid), Function (Binding, Crystallization, Emulsifying, Leavening, Preservatives, Thickening), Distribution Channel (Convenience Stores, Medical and Drug Stores, Online Store, Supermarkets/Hypermarkets), Application (Bakery and Confectionery, Dietary Supplements, Feed, Food and Beverages, Ice Cream, Meat Products, Personal Care and Cosmetics, Protein and Nutritional Bars) – Industry Trends and Forecast to 2029.
Egg Protein in Pharmaceuticals Market Analysis and Size
Rising consumer awareness of nutritional food, an increase in sports activities, and increased demand for performance nutrition and beverages are the key factors driving the market. The increase in strategic marketing activities undertaken by leading manufacturers to build a larger consumer base and burgeoning demand from developing regions provide opportunities for market growth.
Data Bridge Market Research analyses that the egg protein in pharmaceuticals market was valued at USD 3.23 billion in 2021 and is expected to reach the value of USD 5.35 billion by 2029, at a CAGR of 6.50% during the forecast period of 2022-2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Egg Protein in Pharmaceuticals Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Egg White Powder, Egg Yolk Powder, Whole Egg Protein), Flavour (Flavoured, Regular), Form (Liquid, Powder, Solid), Function (Binding, Crystallization, Emulsifying, Leavening, Preservatives, Thickening), Distribution Channel (Convenience Stores, Medical and Drug Stores, Online Store, Supermarkets/Hypermarkets), Application (Bakery and Confectionery, Dietary Supplements, Feed, Food and Beverages, Ice Cream, Meat Products, Personal Care and Cosmetics, Protein and Nutritional Bars)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Memphis Meats (U.S.), MosaMeat (Netherlands), SuperMeat (Israel), Just, Inc (U.S.), Integriculture (Japan), Aleph Farms Ltd (Israel), Finless Foods Inc. (U.S.), Avant Meats Company Limited (China), Balletic Foods (U.S.), Future Meat Technologies Ltd (Israel), Appleton Meats (Canada), Higher Steaks (U.K.), Biofood Systems LTD (Israel), Fork & Goode (U.S.), Meatable (Netherlands), Mission Barns (U.S.), Bluenalu, Inc. (U.S.), New Age Meats (U.S.), Shiok Meats (Singapore), Seafuture Sustainable Biotech (Canada), Wild Type (U.S.), Lab farm Foods (U.S.), Cubiq Foods (Spain), Kiran Meats (U.S.), and Cell Farm FOOD Tech/Granja Celular S.A (Argentina)
|
|
Opportunities
|
|
Market Definition
The egg is an important food item that provides the human body with micronutrients, fats, and proteins. An egg contains 6gm of protein as well as other nutrients such as vitamin B12, vitamin A, E, K, and folic acid. Egg white contains a lot of protein, including ovotransferrin, ovalbumin, ovomucoid, ovomucin, and lysozyme. Lactose intolerant people can consume egg protein because it is lactose-free. Egg protein is consumed for muscle building and repairing, as well as for weight loss.
Global Egg Protein in Pharmaceuticals Market Dynamics
Drivers
- Rise in fitness trends and a adoption of healthy lifestyle
Rising awareness among people reading the benefits of the products, rising preferences for dietary supplements from athletes, growing fitness trends, and adoption of a healthy lifestyle are some of the major factors that will likely boost the growth of the egg protein in pharmaceuticals market during the forecast period. Breakfast products containing protein and fiber-rich ingredients are in high demand in the market, as an increasing number of consumers around the world are shifting toward a high protein diet to start their day, which is expected to provide valuable retail shelf space and market share globally in the egg protein in pharmaceuticals market.
- Growing demand for clean label products
Clean label products are completely natural, non-GMO, and made with real ingredients, with no additives or preservatives. The main benefit of a clean label product is that consumers can easily read the ingredients and that it is organic and free of chemicals. Companies should have good packaging design, food product transparency, and simple ingredients with functional benefits.
Opportunity
An increasing working population, rising demand for ready-to-use products, and expanding retail markets are some of the factors expected to drive global market growth during the forecast period. The rising popularity of animal protein as a natural ingredient in personal care products is expected to fuel growth in the global egg protein in pharmaceuticals market. Rising disposable income levels, rising food and beverage expenditure, and rising consumer awareness of healthy lifestyles are also expected to drive egg protein in pharmaceuticals market growth.
Restraints
The prevalence of antibodies and hormones, as well as the increasing demand for plant-based protein, will most likely impede the growth of egg protein in the pharmaceuticals market during the forecast period.
This egg protein in pharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the egg protein in pharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
COVID-19 Impact on Egg Protein in Pharmaceuticals Market
During the pandemic, demand for egg protein increased due to the COVID-19 outbreak. During the pandemic, eggs and egg protein products provided nutritious food to maintain immune health. To comply with the restrictions, many farms delivered eggs via e-commerce websites. Individual egg consumption in the United States is expected to exceed 250 eggs in the year 2020. This is primarily due to increased awareness of the health benefits of eating eggs during the pandemic. This resulted in numerous launches in the egg protein market over the previous years to meet consumer demand and serve nutritious food in a variety of desirable forms.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent developments
- St Ewe introduced a line of bottled egg whites into Morrisons stores in the United Kingdom in 2021. The Super Egg Whites are pasteurised free-range egg whites with 11g protein per 100ml, no fat, no cholesterol, and no gluten.
- Z Natural Foods launched their first Whole Egg powder in the United States in 2020. The product tastes great and is simple to store and prepare. One egg contains 14 vitamins and minerals, including choline, lutein, vitamins A, D, K2, phosphorus, selenium, and potassium.
- XXL Nutrition launched their first liquid egg whites product in Europe in 2021. These supplements are sold in supplement stores throughout the United Kingdom and other parts of Europe.
Global Egg Protein in Pharmaceuticals Market Scope
The egg protein in pharmaceuticals market is segmented on the basis of type, flavours, form, distribution channel, application, and function. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Egg White Powder
- Egg Yolk Powder
- Whole Egg Protein
Flavours
- Flavoured
- Regular
Form
- Solid
- Liquid
- Powder
Function
- Binding
- Crystallization
- Emulsifying
- Leavening
- Preservatives
- Thickening
Distribution channel
- Convenience Stores
- Medical and Drug Stores
- Online Store
- Supermarkets/Hypermarkets
Application
- Bakery and Confectionery
- Dietary Supplements
- Feed
- Food and Beverages
- Ice Cream
- Meat Products
- Personal Care and Cosmetics
- Protein and Nutritional Bars
Egg Protein in Pharmaceuticals Market Regional Analysis/Insights
The egg protein in pharmaceuticals market is analysed and market size insights and trends are provided by country, type, flavours, form, distribution channel, application, and function as referenced above.
The countries covered in the egg protein in pharmaceuticals market report are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the egg protein in pharmaceuticals market due to rising consumption of additional protein content as well as increased egg protein production in the region.
India and China are expected to grow in the Asia-Pacific egg protein in pharmaceuticals market from 2022 to 2029 due to the presence of various market players in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Egg Protein in Pharmaceuticals Market Share Analysis
The egg protein in pharmaceuticals market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to egg protein in pharmaceuticals market.
Some of the major players operating in the egg protein in pharmaceuticals market are:
- Memphis Meats (U.S.)
- MosaMeat (Netherlands)
- SuperMeat (Israel)
- Just, Inc (U.S.)
- Integriculture (Japan)
- Aleph Farms Ltd (Israel)
- Finless Foods Inc. (U.S.)
- Avant Meats Company Limited (China)
- Balletic Foods (U.S.)
- Future Meat Technologies Ltd (Israel)
- Appleton Meats (Canada)
- Higher Steaks (U.K.)
- Biofood Systems LTD (Israel)
- Fork & Goode (U.S.)
- Meatable (Netherlands)
- Mission Barns (U.S.)
- Bluenalu, Inc. (U.S.)
- New Age Meats (U.S.)
- Shiok Meats (Singapore)
- Seafuture Sustainable Biotech (Canada)
- Wild Type (U.S.)
- Lab farm Foods (U.S.)
- Cubiq Foods (Spain)
- Kiran Meats (U.S.)
- Cell Farm FOOD Tech/Granja Celular S.A (Argentina)
SKU-